PULSed Field ablAtion of coloRectal Polyps

Inclusion Criteria: * \> 18 years of age. * Ability to review the consent form prior to enrolment into the study • Patients must be mentally capable of understanding the information given • Patients must give written informed consent prior to undergoing any study-specific procedures. * Patients must have at least one polyp (treatment naive, recurrent or residual) measuring \>5mm, located distal to the splenic flexure(i.e descending colon, Sigmoid colon, recto sigmoid junction and the rectum above the dentate line) * Polyp(s) must be classified as Type 1 or Type 2, based on NICE (Narrow Band Imaging International Colorectal Endoscopic) classification; OR Type 1 or Type 2A /2B based on JNET (Japan Narrow Band Imaging Expert Team) classification * Patients must have a World Health Organization (WHO) performance status ≤ 2 . Patients must have a life expectancy of at least 6 months Exclusion Criteria: * \< 18 years of age. * Patients who are incapacitated, unconscious or from a vulnerable population. • Patient who is pregnant or breastfeeding * Patients unable to provide their own informed consent * Patients with complex / challenging polyp(s), including but not limited to those that are: o \>20mm in size o Flat/bulky in shape o Extending beyond 2 haustra folds or occupying more than 1/3rd of the lumenal circumference o Located on the right colon proximal to the splenic flexure, ileocecal valve, hepatic and splenic flexure or dentate line of the rectum o Fibrosis from large lateral spreading lesions * Patients with NICE Type 3 category polyps, OR JNET Type 3 polyps OR Kudo Vi pit pattern polyps * Patients with British Society of Gastroenterology (BSG) category C (high risk polyps). * Five or more polyps in a single patient * Grossly inflamed colonic mucosa with bleeding or ulcers * Implanted colonic stents * Polyposis syndromes